ASX soon to get its first erectile dysfunction company
This is one company that probably won't get a limp reception from the market.Brisbane-based LTR Pharma on Friday opened its $7 million initial public offering to fund its planned launch of a fast-acting treatment for erectile dysfunction.LTR's SPONTAN nasal spray takes effect in just 10 minutes - [...]